AR084545A1 - Preparacion de absorcion percutanea que contiene rivastigmina - Google Patents
Preparacion de absorcion percutanea que contiene rivastigminaInfo
- Publication number
- AR084545A1 AR084545A1 ARP110104888A ARP110104888A AR084545A1 AR 084545 A1 AR084545 A1 AR 084545A1 AR P110104888 A ARP110104888 A AR P110104888A AR P110104888 A ARP110104888 A AR P110104888A AR 084545 A1 AR084545 A1 AR 084545A1
- Authority
- AR
- Argentina
- Prior art keywords
- resin
- percutaneous absorption
- absorption preparation
- rivastigmine
- glycol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00646—Medication patches, e.g. transcutaneous
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Preparación de absorción percutánea para el tratamiento de la demencia que comprende rivastigmina o su sal farmacéuticamente aceptable como un ingrediente activo, un copolímero en bloque de estireno-isopreno-estireno, una resina fijadora, y un plastificante, cuya preparación contiene una pequeña cantidad de rivastigmina pero permite una cantidad suficiente de ingrediente activo penetrado en la piel para lograr un tratamiento efectivo de demencia.Reivindicación 1: Una preparación de absorción percutánea que comprende: (a) una capa soporte; y (b) una capa que contiene droga que comprende rivastigmina de base libre o una sal farmacéuticamente aceptable de la misma, un copolímero en bloque de estireno-isopreno-estireno, una resina fijadora, y un plastificante. Reivindicación 6: La preparación de absorción percutánea de la reivindicación 5, en donde la resina fijadora es al menos una seleccionada del grupo que consiste en una resina de hidrocarburo, una resina de hidrocarburo alifática, una resina de hidrocarburo hidrogenada, una resina a base de rosina, una resina a base de terpeno, y una resina de poliéster. Reivindicación 7: La preparación de absorción percutánea de la reivindicación 1 ó 2, en donde el plastificante es al menos uno seleccionado del grupo que consiste de petróleo, escualano, escualeno, aceite vegetal, aceite sintético, éster de ácido dibásico, goma líquida, éster de ácido graso líquido, glicol dietileno, glicol de polietileno, glicol de salicilato, glicol de propileno, glicol de dipropileno, triacetina, citrato de trietil, y crotamitón.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020100134692A KR101788802B1 (ko) | 2010-12-24 | 2010-12-24 | 리바스티그민을 함유하는 경피흡수제제 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR084545A1 true AR084545A1 (es) | 2013-05-22 |
Family
ID=46314648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110104888A AR084545A1 (es) | 2010-12-24 | 2011-12-22 | Preparacion de absorcion percutanea que contiene rivastigmina |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20130267916A1 (es) |
| EP (1) | EP2654739B1 (es) |
| JP (1) | JP5951637B2 (es) |
| KR (1) | KR101788802B1 (es) |
| CN (1) | CN103313705B (es) |
| AR (1) | AR084545A1 (es) |
| AU (1) | AU2011345574B2 (es) |
| BR (1) | BR112013016266A2 (es) |
| NZ (1) | NZ611920A (es) |
| WO (1) | WO2012087047A2 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150051559A1 (en) * | 2012-04-05 | 2015-02-19 | Sparsha Pharma International Private Limited | Transdermal patch for treatment of dementia or alzheimer type dementia |
| US10758494B2 (en) | 2012-06-12 | 2020-09-01 | KM Transderm Ltd. | Rivastigmine-containing adhesive patch |
| US9895320B2 (en) * | 2012-09-28 | 2018-02-20 | KM Transderm Ltd. | Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer |
| WO2014111790A2 (en) | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
| TWI745577B (zh) * | 2013-06-12 | 2021-11-11 | 日商Ｋｍ特蘭斯達股份有限公司 | 經皮吸收製劑 |
| JP2017039706A (ja) * | 2015-08-19 | 2017-02-23 | ニチバン株式会社 | 皮膚貼付用ハイドロコロイド型粘着剤組成物、及びこれを用いた貼付材 |
| WO2017087354A1 (en) * | 2015-11-16 | 2017-05-26 | Noven Pharmaceuticals, Inc. | Stretchable backing layers for transdermal drug delivery systems |
| EP3501518A4 (en) * | 2016-08-22 | 2020-04-29 | Kyukyu Pharmaceutical Co., Ltd. | TRANSDERMAL PATCH |
| WO2018155682A1 (ja) * | 2017-02-27 | 2018-08-30 | 帝國製薬株式会社 | リバスチグミン含有経皮吸収型製剤 |
| KR101892270B1 (ko) * | 2017-04-07 | 2018-08-27 | 주식회사 삼양사 | 피부자극을 최소화 할 수 있는 경피 흡수용 패취 시스템 |
| WO2019017266A1 (ja) | 2017-07-19 | 2019-01-24 | 帝國製薬株式会社 | リバスチグミン含有経皮吸収型製剤 |
| BR112020024923A2 (pt) * | 2018-06-19 | 2021-03-09 | Lts Lohmann Therapie-Systeme Ag | Sistema terapêutico transdérmico contendo rivastigmina |
| CN108926549A (zh) * | 2018-09-27 | 2018-12-04 | 安徽安科余良卿药业有限公司 | 卡巴拉汀凝胶贴膏及其制备方法 |
| CN111195242B (zh) * | 2018-11-16 | 2022-10-25 | 得生制药股份有限公司 | 经皮吸收贴片 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9800526D0 (en) * | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
| FI20000810A0 (fi) * | 2000-04-06 | 2000-04-06 | Orion Yhtymae Oyj | Jauheinhalaattori |
| CN1571664A (zh) * | 2001-10-17 | 2005-01-26 | 久光制药株式会社 | 经皮吸收型制剂 |
| KR100941909B1 (ko) * | 2002-02-19 | 2010-02-16 | 히사미쓰 세이야꾸 가부시키가이샤 | 경피흡수형 부착제 |
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| US9248104B2 (en) | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
| WO2008044336A1 (fr) * | 2006-10-11 | 2008-04-17 | Hisamitsu Pharmaceutical Co., Inc. | Préparation adhésive contenant un cristal |
| JP2009022730A (ja) * | 2007-06-18 | 2009-02-05 | Kyoritsu Yakuhin Kogyo Kk | 貼付剤 |
| KR101175925B1 (ko) * | 2009-01-02 | 2012-08-22 | 대화제약 주식회사 | 리바스티그민의 간단한 경피흡수제 |
-
2010
- 2010-12-24 KR KR1020100134692A patent/KR101788802B1/ko active IP Right Grant
-
2011
- 2011-12-22 AR ARP110104888A patent/AR084545A1/es unknown
- 2011-12-22 WO PCT/KR2011/009994 patent/WO2012087047A2/en active Application Filing
- 2011-12-22 BR BR112013016266-0A patent/BR112013016266A2/pt not_active IP Right Cessation
- 2011-12-22 NZ NZ611920A patent/NZ611920A/en not_active IP Right Cessation
- 2011-12-22 EP EP11851699.6A patent/EP2654739B1/en active Active
- 2011-12-22 US US13/994,788 patent/US20130267916A1/en not_active Abandoned
- 2011-12-22 JP JP2013546023A patent/JP5951637B2/ja not_active Expired - Fee Related
- 2011-12-22 AU AU2011345574A patent/AU2011345574B2/en not_active Ceased
- 2011-12-22 CN CN201180062504.0A patent/CN103313705B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012087047A3 (en) | 2012-08-16 |
| CN103313705B (zh) | 2015-09-30 |
| WO2012087047A2 (en) | 2012-06-28 |
| NZ611920A (en) | 2015-05-29 |
| US20130267916A1 (en) | 2013-10-10 |
| KR20120072796A (ko) | 2012-07-04 |
| CN103313705A (zh) | 2013-09-18 |
| JP5951637B2 (ja) | 2016-07-13 |
| JP2014508728A (ja) | 2014-04-10 |
| BR112013016266A2 (pt) | 2018-06-26 |
| KR101788802B1 (ko) | 2017-10-20 |
| AU2011345574B2 (en) | 2015-07-16 |
| EP2654739A4 (en) | 2016-07-06 |
| AU2011345574A1 (en) | 2013-07-11 |
| EP2654739B1 (en) | 2020-07-22 |
| EP2654739A2 (en) | 2013-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR084545A1 (es) | Preparacion de absorcion percutanea que contiene rivastigmina | |
| BR112012030653A2 (pt) | composição tópica em aerosol, estável ao armazenamento e substancialmente anidra, e, recipiente pressurizado | |
| AR096521A1 (es) | Sistema de liberación transdérmico, uso, método de fabricación | |
| MX2022010507A (es) | Metodos para reducir riesgo de evento cardiovascular en sujeto con terapia con estatina. | |
| AR089201A1 (es) | Sistema de suministro transdermico | |
| TWI501790B (zh) | Contains percutaneous absorption preparations from Donepezil | |
| WO2008069283A1 (ja) | 外用医薬組成物及び貼付剤 | |
| PE20151147A1 (es) | Sistema de liberacion transdermica | |
| AR090491A1 (es) | Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fumarato de dimetilo | |
| RU2012120745A (ru) | Трансдермально абсорбируемый состав, содержащий донепезил | |
| KR20110124771A (ko) | 진통·항염증제 함유 외용제 | |
| JPWO2009031318A1 (ja) | 鎮痛・抗炎症剤含有外用剤 | |
| AR122269A1 (es) | Uso de ésteres de poliglicerol como vehículo para ingredientes microbiológicos activos | |
| CN101932329A (zh) | 贴剂 | |
| AR067446A1 (es) | Un medicamento para tratar higado graso que comprende cilostazol | |
| AR084235A1 (es) | Composiciones farmaceuticas que comprenden alisporivir | |
| ECSP13013095A (es) | Composición farmacéutica que comprende fexofenadina | |
| JP2009280509A (ja) | 鎮痛・抗炎症剤含有外用剤 | |
| AR095538A1 (es) | Composiciones farmacéuticas de ésteres de testosterona de cadena larga lipoequilibrados para la administración oral | |
| AR086447A1 (es) | Composicion farmaceutica que comprende ketoprofeno | |
| US20090028806A1 (en) | Medicine for External Application Containing Anti-Inflammatory Agent and Soy Lecithin | |
| KR101976248B1 (ko) | 에메다스틴 함유 테이프제 | |
| EA201692083A1 (ru) | Фармацевтическая композиция для ветеринарии и ее применение | |
| JPWO2013183407A1 (ja) | ミルタザピン含有経皮吸収型貼付製剤 | |
| HRP20200380T1 (hr) | Pripravak koji sadrži ester alfa-tokoferola za prevenciju i liječenje alergijskog rinitisa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |